Clinical Trials Browser

Phase 2 × Drug-Related Side Effects and Adverse Reactions × Tegafur × Clear all

NCT02447679 2017-02-07

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Drug-Related Side Effects and Adverse Reactions